Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for CTEV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -294.56M
March 31, 2026 -241.14M
December 31, 2025 -173.90M
September 30, 2025 -101.84M
June 30, 2025 -39.91M
March 31, 2025 14.82M
December 31, 2024 84.02M
September 30, 2024 207.56M
June 30, 2024 603.36M
March 31, 2024 1.170B
December 31, 2023 1.709B
September 30, 2023 1.750B
June 30, 2023 1.769B
March 31, 2023 1.788B
Date Value
December 31, 2022 1.791B
September 30, 2022 2.437B
June 30, 2022 2.409B
March 31, 2022 2.391B
December 31, 2021 2.345B
September 30, 2021 2.355B
June 30, 2021 2.335B
March 31, 2021 2.377B
December 31, 2020 2.558B
September 30, 2020 1.058B
June 30, 2020 1.067B
March 31, 2020 1.068B
December 31, 2019 0.0236M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. 7.053M
SCWorx Corp. 6.932M
Health Catalyst, Inc. 100.83M
GoodRx Holdings, Inc. 647.60M
iSpecimen, Inc. 1.736M

Shareholders Equity (Quarterly) Related Metrics